[HTML][HTML] Renal delivery of pharmacologic agents during machine perfusion to prevent ischaemia-reperfusion injury: from murine model to clinical trials
Donor organ shortage still remains a serious obstacle for the access of wait-list patients to
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials.
R Franzin, A Stasi, M Fiorentino, S Simone… - Frontiers in …, 2021 - europepmc.org
Donor organ shortage still remains a serious obstacle for the access of wait-list patients to
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials
R Franzin, A Stasi, M Fiorentino, S Simone… - FRONTIERS IN …, 2021 - air.unimi.it
Donor organ shortage still remains a serious obstacle for the access of wait-list patients to
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials
R Franzin, A Stasi, M Fiorentino, S Simone… - FRONTIERS IN …, 2021 - ricerca.uniba.it
Donor organ shortage still remains a serious obstacle for the access of wait-list patients to
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials
R Franzin, A Stasi, M Fiorentino… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Donor organ shortage still remains a serious obstacle for the access of wait-list patients to
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
[HTML][HTML] Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials
R Franzin, A Stasi, M Fiorentino, S Simone… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Donor organ shortage still remains a serious obstacle for the access of wait-list patients to
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
[引用][C] Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials
R Franzin, A Stasi, M Fiorentino, S Simone… - … in Immunology (Web), 2021 - jglobal.jst.go.jp
Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion
Injury: From Murine Model to Clinical Trials | Article Information | J-GLOBAL Art J-GLOBAL ID:202102218906784305 …
Injury: From Murine Model to Clinical Trials | Article Information | J-GLOBAL Art J-GLOBAL ID:202102218906784305 …
[PDF][PDF] Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials
R Franzin, A Stasi, M Fiorentino, S Simone… - Front. Immunol. 12 …, 2021 - air.unimi.it
Donor organ shortage still remains a serious obstacle for the access of wait-list patients to
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …